(Reuters) -Juul Labs Inc on Friday secured preliminary court approval of a $255 million settlement resolving claims by consumers that it deceptively marketed e-cigarettes, as the company seeks to resolve thousands of lawsuits.
U.S. District Judge William Orrick in San Francisco said the proposed class action settlement resolving claims by consumers who said they overpaid for Juul's vaping products was "fair, reasonable, and adequate," according to a court filing.
The settlement is part of a larger, global agreement by Juul to resolve thousands of lawsuits by school districts, local governments and individuals accusing it of contributing to a youth vaping epidemic.
The company last month said it had reached settlements with about 10,000 plaintiffs covering more than 5,000 cases. It has not said how much it will pay, though the Wall Street Journal reported deal is valued at $1.7 billion.
The class action settlement resolves claims by people who say they would have paid less, or not bought the e-cigarettes at all, if Juul had not downplayed the products' addictiveness and appealed to teenagers through social media campaigns and other means.
Juul did not respond to a request for comment.
Partly owned by Marlboro maker Altria Group Inc, Juul in September agreed to pay $438.5 million to settle claims from 34 U.S. states and territories that said the company targeted underage buyers and downplayed its products' risks.
The U.S. Food and Drug Administration in June briefly banned Juul's e-cigarettes, though it later put the order on hold following an appeal.
(Reporting by Deborah Sophia in Bengaluru; Additional reporting by Maria Ponnezhath and Nate Raymond; Editing by Devika Syamnath, Leslie Adler and William Mallard)
lasix order And this morning we got a POSITIVE PREGNANCY TESTREPLY
Targeted anti vascular therapies for ovarian cancer current evidence kamagra pharmacyyREPLY
Liquidliquid extraction technique LLE using ethyl acetate was applied in order to optimize the recovery of analytes in mice plasma cheap generic cialis It is a derivative of minocyclineREPLY